Article
Hierarchically supervised computational pathology stratifies HER2 categories and ERBB2 amplification risk from routine H&E slides in breast cancer
2026-06-29
Abstract excerpt
<title>Abstract</title> <p> The equivocal human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) 2 + boundary remains a treatment-defining bottleneck in breast oncology because amplification adjudication requires resource-intensive in situ hybridisation/fluorescence in situ hybridisation (ISH/FISH) confirmation. This process is further constrained by turnaround time, manual signal interpretat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ef0ad40-1124-5efc-adb0-f76c4b44c757
- DOI
- 10.21203/rs.3.rs-10166827/v1
